Similar articles

• The prevalence of hereditary antithrombin-III deficiency in patients with a history of venous thromboembolism.

  Vikydal R, Korninger C, Kyrle PA, Niessner H, Pabinger I, Thaler E, Lechner K. Vikydal R, et al. Thromb Haemost. 1985 Dec 17;54(4):744-5. Thromb Haemost. 1985. PMID: 4089808
• [Plasma antithrombin III activity in patients with pulmonary thromboembolism].

  Vertun B, Filipecki S, Szczepański M, Wawrzyńska L, Rózycka J. Vertun B, et al. Pol Tyg Lek. 1992 Aug 18-31;47(34-35):726-9. Pol Tyg Lek. 1992. PMID: 1488357 Polish.
• Types of AT III abnormalities and their significance in hypercoagulability.

  Nagy I, Losonczy H. Nagy I, et al. Folia Haematol Int Mag Klin Morphol Blutforsch. 1984;111(4):421-5. Folia Haematol Int Mag Klin Morphol Blutforsch. 1984. PMID: 6083906 No abstract available.
• [Prevention of thromboembolism in trauma surgery and orthopedics].

  Haas S, Haas P. Haas S, et al. Chirurg. 1992 Apr;63(4):271-5. Chirurg. 1992. PMID: 1597090 Review. German. No abstract available.
• Antithrombin III deficiency and thromboembolism.

  Thaler E, Lechner K. Thaler E, et al. Clin Haematol. 1981 Jun;10(2):369-90. Clin Haematol. 1981. PMID: 7032781 Review. No abstract available.